Overexpression of methyl-CpG binding protein 2 impairs TH1 responses

Science Translational Medicine

Volumn 4, Issue 163, 2012, Pages

  Yang, Tianshu ^a   Ramocki, Melissa B ^a   Neul, Jeffrey L ^a   Lu, Wen ^a   Roberts, Luz ^a   Knight, John ^a   Ward, Christopher S ^a   Zoghbi, Huda Y ^a,b   Kheradmand, Farrah ^a,c   Corry, David B ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD27 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD45RO ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 17; INTERLEUKIN 4; METHYL CPG BINDING PROTEIN 2; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR T BET;

ADULT; ALLERGIC REACTION; ANIMAL CELL; ARTICLE; ASPERGILLUS NIGER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINEAGE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE; GENE DUPLICATION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPHENOTYPING; INFECTION CONTROL; LEISHMANIA MAJOR; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MECP2 GENE; MEMORY CELL; MEMORY T LYMPHOCYTE; MOUSE; MYCOSIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; TH1 CELL; TH2 CELL;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; FLOW CYTOMETRY; GENE DUPLICATION; HUMANS; INTERFERON-GAMMA; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; METHYL-CPG-BINDING PROTEIN 2; MICE; RNA, SMALL INTERFERING; TH1 CELLS;

EID: 84870720893     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3004430     Document Type: Article

References (44)

1. J. Guy, H. Cheval, J. Selfridge, A. Bird, The role of MeCP2 in the brain. Annu. Rev. Cell Dev. Biol. 27, 631-652 (2011).
2. H. Lubs, F. Abidi, J. A. Bier, D. Abuelo, L. Ouzts, K. Voeller, E. Fennell, R. E. Stevenson, C. E. Schwartz, F. Arena, XLMR syndrome characterized by multiple respiratory infections, hypertelorism, severe CNS deterioration and early death localizes to distal Xq28. Am. J. Med. Genet. 85, 243-248 (1999).
3. M. B. Ramocki, Y. J. Tavyev, S. U. Peters, The MECP2 duplication syndrome. Am. J. Med. Genet. A 152A, 1079-1088 (2010).
4. H. Van Esch, M. Bauters, J. Ignatius, M. Jansen, M. Raynaud, K. Hollanders, D. Lugtenberg, T. Bienvenu, L. R. Jensen, J. Gecz, C. Moraine, P.Marynen, J. P. Fryns, G. Froyen, Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet. 77, 442-453 (2005).
5. C. M. Carvalho, F. Zhang, P. Liu, A. Patel, T. Sahoo, C. A. Bacino, C. Shaw, S. Peacock, A. Pursley, Y. J. Tavyev, M. B. Ramocki, M. Nawara, E. Obersztyn, A. M. Vianna-Morgante, P. Stankiewicz, H. Y. Zoghbi, S. W. Cheung, J. R. Lupski, Complex rearrangements in patients with duplications of MECP2 can occur by fork stalling and template switching. Hum. Mol. Genet. 18, 2188-2203 (2009).
6. D. del Gaudio, P. Fang, F. Scaglia, P. A. Ward, W. J. Craigen, D. G. Glaze, J. L. Neul, A. Patel, J. A. Lee, M. Irons, S. A. Berry, A. A. Pursley, T. A. Grebe, D. Freedenberg, R. A. Martin, G. E. Hsich, J. R. Khera, N. R. Friedman, H. Y. Zoghbi, C. M. Eng, J. R. Lupski, A. L. Beaudet, S. W. Cheung, B. B. Roa, Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet. Med. 8, 784-792 (2006).
7. A. L. Collins, J. M. Levenson, A. P. Vilaythong, R. Richman, D. L. Armstrong, J. L. Noebels, J. David Sweatt, H. Y. Zoghbi, Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13, 2679-2689 (2004).
8. C. M. Carvalho, M. B. Ramocki, D. Pehlivan, L. M. Franco, C. Gonzaga-Jauregui, P. Fang, A. McCall, E. K. Pivnick, S. Hines-Dowell, L. H. Seaver, L. Friehling, S. Lee, R. Smith, D. Del Gaudio, M.Withers, P. Liu, S. W. Cheung, J. W. Belmont, H. Y. Zoghbi, P. J. Hastings, J. R. Lupski, Inverted genomic segments and complex triplication rearrangements are mediated by inverted repeats in the human genome. Nat. Genet. 43, 1074-1081 (2011).
9. M. J. Friez, J. R. Jones, K. Clarkson, H. Lubs, D. Abuelo, J. A. Bier, S. Pai, R. Simensen, C. Williams, P. F. Giampietro, C. E. Schwartz, R. E. Stevenson, Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics 118, e1687-e1695 (2006).
10. S. S. Tang, D. Fernandez, L. P. Lazarou, R. Singh, P. Fallon, MECP2 triplication in 3 brothers - A rarely described cause of familial neurological regression in boys. Eur. J. Paediatr. Neurol. 16, 209-212 (2012).
11. S. Gottipati, N. L. Rao, W. P. Fung-Leung, IRAK1: A critical signaling mediator of innate immunity. Cell. Signal. 20, 269-276 (2008).
12. A. Tun-Kyi, G. Finn, A. Greenwood, M. Nowak, T. H. Lee, J. M. Asara, G. C. Tsokos, K. Fitzgerald, E. Israel, X. Li, M. Exley, L. K. Nicholson, K. P. Lu, Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity. Nat. Immunol. 12, 733-741 (2011).
13. C. Deng, C. Radu, A. Diab, M. F. Tsen, R. Hussain, J. S. Cowdery, M. K. Racke, J. A. Thomas, IL-1 receptor-associated kinase 1 regulates susceptibility to organ-specific autoimmunity. J. Immunol. 170, 2833-2842 (2003).
14. M. D. Shahbazian, B. Antalffy, D. L. Armstrong, H. Y. Zoghbi, Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 11, 115-124 (2002).
15. A. Dhasarathy, P. A. Wade, The MBD protein family - Reading an epigenetic mark? Mutat. Res. 647, 39-43 (2008).
16. J. C. de Greef, J. Wang, J. Balog, J. T. den Dunnen, R. R. Frants, K. R. Straasheijm, C. Aytekin, M. van der Burg, L. Duprez, A. Ferster, A. R. Gennery, G. Gimelli, I. Reisli, C. Schuetz, A. Schulz, D. F. Smeets, Y. Sznajer, C. Wijmenga, M. C. van Eggermond, M. M. van Ostaijen-Ten Dam, A. C. Lankester, M. J. van Tol, P. J. van den Elsen, C. M. Weemaes, S. M. van der Maarel, Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Am. J. Hum. Genet. 88, 796-804 (2011).
17. R. C. Samaco, C. Mandel-Brehm, C. M. McGraw, C. A. Shaw, B. E. McGill, H. Y. Zoghbi, Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome. Nat. Genet. 44, 206-211 (2012).
18. S. L. Reiner, R. M. Locksley, The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13, 151-177 (1995).
19. T. L. Stevens, A. Bossie, V. M. Sanders, R. Fernandez-Botran, R. L. Coffman, T. R. Mosmann, E. S. Vitetta, Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334, 255-258 (1988).
20. N. Rao, S. Nguyen, K. Ngo, W. P. Fung-Leung, A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling. Mol. Cell. Biol. 25, 6521-6532 (2005).
21. Y. Tong, T. Aune, M. Boothby, T-bet antagonizes mSin3a recruitment and transactivates a fully methylated IFN-g promoter via a conserved T-box half-site. Proc. Natl. Acad. Sci. U.S.A. 102, 2034-2039 (2005).
22. S. J. Szabo, S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, L. H. Glimcher, A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669 (2000).
23. B. Jones, J. Chen, Inhibition of IFN-g transcription by site-specific methylation during T helper cell development. EMBO J. 25, 2443-2452 (2006).
24. V. H. Adams, S. J. McBryant, P. A. Wade, C. L. Woodcock, J. C. Hansen, Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2. J. Biol. Chem. 282, 15057-15064 (2007).
25. R. R. Meehan, J. D. Lewis, A. P. Bird, Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res. 20, 5085-5092 (1992).
26. P. T. Georgel, R. A. Horowitz-Scherer, N. Adkins, C. L. Woodcock, P. A. Wade, J. C. Hansen, Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J. Biol. Chem. 278, 32181-32188 (2003).
27. M. Chahrour, S. Y. Jung, C. Shaw, X. Zhou, S. T. Wong, J. Qin, H. Y. Zoghbi, MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224-1229 (2008).
28. S. Cohen, H. W. Gabel, M. Hemberg, A. N. Hutchinson, L. A. Sadacca, D. H. Ebert, D. A. Harmin, R. S. Greenberg, V. K. Verdine, Z. Zhou, W. C. Wetsel, A. E. West, M. E. Greenberg, Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72, 72-85 (2011).
29. S. Chang, P. L. Collins, T. M. Aune, T-bet dependent removal of Sin3A-histone deacetylase complexes at the Ifng locus drives Th1 differentiation. J. Immunol. 181, 8372-8381 (2008).
30. X. Nan, H. H. Ng, C. A. Johnson, C. D. Laherty, B. M. Turner, R. N. Eisenman, A. Bird, Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389 (1998).
31. I. Sologuren, S. Boisson-Dupuis, J. Pestano, Q. B. Vincent, L. Fernández-Pérez, A. Chapgier, M. Cárdenes, J. Feinberg, M. I. García-Laorden, C. Picard, E. Santiago, X. Kong, L. Jannière, E. Colino, E. Herrera-Ramos, A. Francés, C. Navarrete, S. Blanche, E. Faria, P. Remiszewski, A. Cordeiro, A. Freeman, S. Holland, K. Abarca, M. Valerón-Lemaur, J. Gonçalo-Marques, L. Silveira, J. M. García-Castellano, J. Caminero, J. L. Pérez-Arellano, J. Bustamante, L. Abel, J. L. Casanova, C. Rodriguez-Gallego, Partial recessive IFN-gR1 deficiency: Genetic, immunological and clinical features of 14 patients from 11 kindreds. Hum. Mol. Genet. 20, 1509-1523 (2011).
32. D. Vairo, L. Tassone, G. Tabellini, N. Tamassia, S. Gasperini, F. Bazzoni, A. Plebani, F. Porta, L. D. Notarangelo, S. Parolini, S. Giliani, R. Badolato, Severe impairment of IFN-γ and IFN-αresponses in cells of a patient with a novel STAT1 splicing mutation. Blood 118, 1806-1817 (2011).
33. C. Prando, S. Boisson-Dupuis, A. V. Grant, X. F. Kong, J. Bustamante, J. Feinberg, A. Chapgier, Y. Rose, L. Janniere, E. Rizzardi, Q. Zhang, C. M. Shanahan, L. Viollet, S. Lyonnet, L. Abel, E. M. Ruga, J. L. Casanova, Paternal uniparental isodisomy of chromosome 6 causing a complex syndrome including complete IFN-g receptor 1 deficiency. Am. J. Med. Genet. A 152A, 622-629 (2010).
34. D. Averbuch, A. Chapgier, S. Boisson-Dupuis, J. L. Casanova, D. Engelhard, The clinical spectrum of patients with deficiency of signal transducer and activator of transcription-1. Pediatr. Infect. Dis. J. 30, 352-355 (2011).
35. L. de Beaucoudrey, A. Samarina, J. Bustamante, A. Cobat, S. Boisson-Dupuis, J. Feinberg, S. Al-Muhsen, L. Jannière, Y. Rose, M. de Suremain, X. F. Kong, O. Filipe-Santos, A. Chapgier, C. Picard, A. Fischer, F. Dogu, A. Ikinciogullari, G. Tanir, S. Al-Hajjar, S. Al-Jumaah, H. H. Frayha, Z. AlSum, S. Al-Ajaji, A. Alangari, A. Al-Ghonaium, P. Adimi, D. Mansouri, I. Ben-Mustapha, J. Yancoski, B. Z. Garty, C. Rodriguez-Gallego, I. Caragol, N. Kutukculer, D. S. Kumararatne, S. Patel, R. Doffinger, A. Exley, O. Jeppsson, J. Reichenbach, D. Nadal, Y. Boyko, B. Pietrucha, S. Anderson, M. Levin, L. Schandené, K. Schepers, A. Efira, F. Mascart, M. Matsuoka, T. Sakai, C. A. Siegrist, K. Frecerova, R. Bluetters-Sawatzki, J. Bernhöft, J. Freihorst, U. Baumann, D. Richter, F. Haerynck, F. De Baets, V. Novelli, D. Lammas, C. Vermylen, D. Tuerlinckx, C. Nieuwhof, M. Pac, W. H. Haas, I. Muller-Fleckenstein, B. Fleckenstein, J. Levy, R. Raj, A. C. Cohen, D. B. Lewis, S. M. Holland, K. D. Yang, X. Wang, X. Wang, L. Jiang, X. Yang, C. Zhu, Y. Xie, P. P. Lee, K. W. Chan, T. X. Chen, G. Castro, I. Natera, A. Codoceo, A. King, L. Bezrodnik, D. Di Giovani, M. I. Gaillard, D. de Moraes- Vasconcelos, A. S. Grumach, A. J. da Silva Duarte, R. Aldana, F. J. Espinosa-Rosales, M. Bejaoui, A. A. Bousfiha, J. E. Baghdadi, N. Ozbek, G. Aksu, M. Keser, A. Somer, N. Hatipoglu, C. Aydogmus, S. Asilsoy, Y. Camcioglu, S. Gülle, T. T. Ozgur, M. Ozen, M. Oleastro, A. Bernasconi, S. Mamishi, N. Parvaneh, S. Rosenzweig, R. Barbouche, S. Pedraza, Y. L. Lau,M. S. Ehlayel, C. Fieschi, L. Abel, O. Sanal, J. L. Casanova, Revisiting human IL-12Rβ1 deficiency: A survey of 141 patients from 30 countries. Medicine 89, 381-402 (2010).
36. S. M. Gordon, J. Chaix, L. J. Rupp, J. Wu, S. Madera, J. C. Sun, T. Lindsten, S. L. Reiner, The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36, 55-67 (2012).
37. M. Alvarez-Saavedra, M. A. Sáez, D. Kang, H. Y. Zoghbi, J. I. Young, Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis. Hum. Mol. Genet. 16, 2315-2325 (2007).
38. S. Grumelli, D. B. Corry, L. Z. Song, L. Song, L. Green, J. Huh, J. Hacken, R. Espada, R. Bag, D. E. Lewis, F. Kheradmand, An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med. 1, e8 (2004).
39. D. B. Corry, S. L. Reiner, P. S. Linsley, R. M. Locksley, Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 153, 4142-4148 (1994).
40. L. Soong, J. C. Xu, I. S. Grewal, P. Kima, J. Sun, B. J. Longley Jr., N. H. Ruddle, D. McMahon-Pratt, R. A. Flavell, Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4, 263-273 (1996).
41. D. B. Corry, H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, R. M. Locksley, Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183, 109-117 (1996).
42. F. Kheradmand, A. Kiss, J. Xu, S. H. Lee, P. E. Kolattukudy, D. B. Corry, A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J. Immunol. 169, 5904-5911 (2002).
43. D. B. Corry, G. Grünig, H. Hadeiba, V. P. Kurup, M. L. Warnock, D. Sheppard, D. M. Rennick, R. M. Locksley, Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol. Med. 4, 344-355 (1998).
44. J. Xu, P. W. Park, F. Kheradmand, D. B. Corry, Endogenous attenuation of allergic lung inflammation by syndecan-1. J. Immunol. 174, 5758-5765 (2005).